opioid epidemic News

Judge Shields Oxycontin-Maker Purdue From Litigation Until April

Purdue Pharma LP and the company’s Sackler family owners will be shielded until April 8, 2020, from sprawling opioid litigation to give the maker of OxyContin time to try to reach a legal settlement the company says is worth $10 …

Drug Distributor Reckitt to Pay $700 Million Over Opioid Marketing

Drug distributor Reckitt Benckiser Group agreed to a $700 million settlement with six U.S. states over claims that the company improperly marketed and promoted the opioid-addiction treatment Suboxone. The marketing resulted in state Medicaid funds being improperly spent on the …

$50 Billion Opioid Settlement Bid Sparks States-Cities Fight

About $50 billion in settlement offers by drugmakers and distributors have sparked a fight between state attorneys general and thousands of local governments over how much the pharmaceutical industry should pay for its role in creating the U.S. opioid epidemic. …

Drug Wholesalers, Teva Settle With Ohio Counties Over Opioids

The three largest U.S. drug distributors and a major generic-drug manufacturer have agreed to pay $260 million to settle the first federal trial over the companies’ role in fueling the U.S. opioid epidemic. Drug distributors McKesson Corp., Cardinal Health Inc. …

J&J Makes $4 Billion Opioid Offer as Distributors Seek Deal

Johnson & Johnson has offered to pay $4 billion to settle all claims accusing the company of helping fuel the U.S. opioid epidemic, as part of a potentially larger deal involving drugmakers and distributors that could top $20 billion. J&J’s …

Sacklers to Remain Billionaire Family If Purdue Settles Opioid Lawsuits

The Sackler family — once known as global philanthropists backed by a fortune made from opioids and other drugs — may lose most of their wealth if they agree to an $11.5 billion settlement to resolve lawsuits against them and …

Sackler Family Backs $11.5 Billion Purdue Opioid Settlement

The Sackler family and their embattled drugmaker, Purdue Pharma LP, are backing a proposal to resolve all opioid lawsuits against themselves and the company for more than $11 billion in what would be the largest settlement to date in the …

Opioid Fines Could Reach $150 Billion in Worst-Case Scenario

Monday’s $572 million judgment against Johnson & Johnson may mean one analyst’s “bear case scenario” of $150 billion in opioid damages just got one step closer. Patrick Trucchio, a Berenberg analyst, on Tuesday renewed his April projection for U.S. liabilities …

Teva’s Budding Blockbuster Drugs Lend Respite From Legal Concerns

Teva Pharmaceutical Industries Ltd. is preparing for a potential reckoning with the U.S. epidemic of opioid addiction. The drugmaker’s shares tumbled after it set aside $646 million to help pay legal expenses related to its alleged role in the abuse …

Opioid Distributors Propose $10 Billion to End State Claims

McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp. have proposed paying $10 billion to settle claims they helped to fuel the U.S. opioid epidemic — the first sign of progress in resolving state lawsuits against the drug distributors, according to …